Republic of Korea
9 Vaccines Approved for Use in Republic of Korea
Protein Subunit
RNA
Moderna
Spikevax
Approved in 88 countries
70 trials in 24 countries
Approval Source: modernatx.gcs-web.com
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: asia.nikkei.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: mfds.go.kr
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Protein Subunit
SK Bioscience Co Ltd
SKYCovione
Approved in 1 country
7 trials in 6 countries
Approval Source: ipd.uw.edu
RNA
Moderna
Spikevax Bivalent Original/Omicron BA.1
Approved in 38 countries
5 trials in 4 countries
Approval Source: kukinews.com
RNA
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.1
Approved in 35 countries
3 trials in 5 countries
Approval Source: koreabiomed.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: mfds.go.kr
10 in Clinical Trials in Republic of Korea
Protein Subunit
SK Bioscience Co Ltd
GBP510
6 trials in 6 countries
DNA
Inovio
INO-4800
10 trials in 9 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Protein Subunit
EuBiologics Co Ltd
EuCorVac-19
4 trials in 3 countries
DNA
GeneOne Life Science, Inc.
GLS-5310
4 trials in 2 countries
Replicating Viral Vector
Cellid Co
AdCLD-CoV19
5 trials in 1 country
Protein Subunit
SK Bioscience Co Ltd
NBP2001
Protein Subunit
HK inno.N Corporation
IN-B009
Non Replicating Viral Vector
Cellid Co
AdCLD-CoV19-1
Protein Subunit
SK Bioscience Co Ltd
SKYCovione
Approved in 1 country
7 trials in 6 countries
1 Vaccines with Trials in Republic of Korea are No Longer Progressing
DNA
Genexine
GX-19
7 trials in 1 country